HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Motapizone

HCID 65819
NotesReactions
Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
90697-57-7
Standard SMILES
CC1CC(=O)NN=C1c1cc(-n2ccnc2)cs1
InChIKey
NPFVRBCDMFKOPY-UHFFFAOYSA-N
Molecular formula
C12H12N4OS
Average molar mass
260.32 g/mol
Monoisotopic mass
260.07318219

Overview

structure given in first source

Names & identifiers

Preferred name
Motapizone
IUPAC
3-(4-imidazol-1-ylthiophen-2-yl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one
English name
Motapizone
Molecular formula
C12H12N4OS
Molecular weight
260.31

Names & synonyms

Motapizone90697-57-7MotapizonMotapizonaMotapizonumC4A61P8A37NAT-05-2394,5-dihydro-6-(4-(1H-imidazol-1-yl)-2-thienyl)-5-methyl-3(2H)-pyridazinoneRefChem:159828Motapizone [INN]NAT 05-2393-(4-imidazol-1-ylthiophen-2-yl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one
Show more names
4,5-Dihydro-6-[4-(1H-imidazol-1-yl)-2-thienyl]-5-methylpyridazin-3(2H)-one3(2H)-Pyridazinone, 4,5-dihydro-6-[4-(1H-imidazol-1-yl)-2-thienyl]-5-methyl-
6-[4-(1H-imidazol-1-yl)thiophen-2-yl]-5-methyl-2,3,4,5-tetrahydropyridazin-3-one(+-)-4,5-Dihydro-6-(4-imidazol-1-yl-2-thienyl)-5-methyl-3(2H)-pyridazinoneMotapizonum [Latin]Motapizona [Spanish]UNII-C4A61P8A37SCHEMBL385669orb1983549CHEMBL2104670

Database identifiers

CAS
90697-57-7
PubChem CID
65819
DTXSID
DTXSID30869061
ChEMBL
CHEMBL2104670
UNII

Properties

Computed structural properties

XLogP
1.3
Topological polar surface area
87.5 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
4
Rotatable bonds
2
Heavy atoms
18
Formal charge
0
Complexity
373

Physicochemical properties

form
Solid
color
Light yellow to yellow
FDA UNII
4 A61P8A37 · C4A61P8A37

Chemistry & industry

Applications · 1 item

UsesMotapizone (NAT 05-239) is a selective PDE3 inhibitor. Motapizone moderately inhibits cytokine release in lipopolysaccharide (LPS)-induced alveolar macrophages. Motapizone also inhibits human platelet aggregation by increasing intracellular cAMP[1][2].

Suppliers4 total

2A PharmaChem USA[email protected]
Leancare Ltd.[email protected]
Lanospharma Laboratories Co.,Ltd13440048448 · [email protected]
3B Scientific Corporation[email protected]

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
C4A61P8A37
Nikkaji
J22.759E